Viral Pricing: Rising medicine prices and extensive patenting have affected the lives of European patients for years. Considering the implementation of the new Pharmaceutical Strategy of Europe and the increasing value of the pharmaceutical market, how can the EU ensure safe and accessible medicine for all?